Cargando…
PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma
OBJECTIVE: Osteosarcoma is the most common primary bone tumor and most frequently develops during adolescence. PLOD family was mainly involved in lysyl hydroxylation and rarely investigated in cancers, especially in osteosarcoma. The aim of this study was to investigate the expression pattern and on...
Autores principales: | Jiang, Haoli, Guo, Wei, Yuan, Shanyou, Song, Lixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593720/ https://www.ncbi.nlm.nih.gov/pubmed/33134376 http://dx.doi.org/10.1155/2020/3418398 |
Ejemplares similares
-
Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
por: Yang, Bo, et al.
Publicado: (2020) -
PB1798: EVALUATION OF EXPRESSION OF PLODS FAMILY GENES (PLOD1, PLOD2, PLOD3) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Zaker, F., et al.
Publicado: (2022) -
Perioperative blood loss during joint replacement: comparison between patients with and without hemophilia
por: Yuan, Shanyou, et al.
Publicado: (2022) -
Expression and Prognostic Role of PLOD1 in Malignant Glioma
por: Wang, Hao, et al.
Publicado: (2020) -
Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma
por: Sun, Yawei, et al.
Publicado: (2021)